Testing effectiveness (Phase 2)Study completedNCT00262834
What this trial is testing
Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer
Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
National Cancer Institute (NCI) 54